Using gold nanorods core/silver shell nanostructures as model material to probe biodistribution and toxic effects of silver nanoparticles in mice

Nanotoxicology

Volumn 8, Issue 6, 2014, Pages 686-696

  Meng, Jie ^a   Ji, Yinglu ^b   Liu, Jian ^a   Cheng, Xuelian ^a   Guo, Hua ^a   Zhang, Weiqi ^a   Wu, Xiaochun ^b   Xu, Haiyan ^a  

^a INSTITUTE OF BASIC MEDICAL SCIENCES   (China)

^b NATIONAL CENTER FOR NANOSCIENCE AND TECHNOLOGY   (China)

Author keywords

Biodistribution; Complement activation; Kidney; Silver nanoparticles; Subcutaneous administration

Indexed keywords

GOLD NANOPARTICLE; NANOMATERIAL; NANOROD; SILVER NANOPARTICLE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; IN VIVO STUDY; LYMPH NODE; MALE; NONHUMAN; PHYSIOLOGY; PRIORITY JOURNAL; SUBCUTANEOUS TISSUE; TOXICITY;

ANIMALS; FEMALE; GOLD; INJECTIONS, SUBCUTANEOUS; KIDNEY; KIDNEY GLOMERULUS; MICE; MICE, INBRED BALB C; NANOTUBES; SILVER; TISSUE DISTRIBUTION;

EID: 84890424862     PISSN: 17435390     EISSN: 17435404     Source Type: Journal    
DOI: 10.3109/17435390.2013.822593     Document Type: Article

References (48)

1. Ahamed M, Alsalhi MS, Siddiqui MK. 2010. Silver nanoparticle applications and human health. Clin Chim Acta 411:1841-1848
2. Austin LA, Kang B, Yen CW, El-Sayed MA. 2011. Nuclear targeted silver nanospheres perturb the cancer cell cycle differently than those of nanogold. Bioconjug Chem 22:2324-2331
3. Babu MM, Sridhar J, Gunasekaran P. 2011. Global transcriptome analysis of Bacillus cereus ATCC 14579 in response to silver nitrate stress. J Nanobiotechnol 9:49
4. Bigazzi PE. 1999. Metals and kidney autoimmunity. Environ Health Perspect 107:753-765
5. Braydich-Stolle LK, Lucas B, Schrand A, Murdock RC, Lee T, Schlager JJ, et al. 2010. Silver nanoparticles disrupt GDNF/Fyn kinase signaling in spermatogonial stem cells. Toxicol Sci 116: 577-589
6. Carr KE, Hazzard RA, Reid S, Hodges GM. 1996. The effect of size on uptake of orally administered latex microparticles in the small intestine and transport to mesenteric lymph nodes. Pharm Res 13:1205-1209
7. Chaloupka K, Malam Y, Seifalian AM. 2010. Nanosilver as a new generation of nanoproduct in biomedical applications. Trends Biotechnol 28:580-588
8. Cheng XL, Zhang WQ, Ji YL, Meng J, Guo H, Liu J, et al. 2013. Revealing silver cytotoxicity using Au nanorods/Ag shell nanostructures: Disrupting cell membrane and causing apoptosis through oxidative damage. RSC Adv 3:2296-2305
9. Cohen MS, Stern JM, Vanni AJ, Kelley RS, Baumgart E, Field D, et al. 2007. In vitro analysis of a nanocrystalline silver-coated surgical mesh. Surg Infect (Larchmt) 8:397-403
10. Comfort KK, Maurer EI, Braydich-Stolle LK, Hussain SM. 2011. Interference of silver, gold, and iron oxide nanoparticles on epidermal growth factor signal transduction in epithelial cells. ACS Nano 5:10000-10008
11. Damm C, Munstedt H. 2008. Kinetic aspects of the silver ion release from antimicrobial polyamide/silver nanocomposites. Appl Phys A Mater Sci Process 91:479-486
12. Danscher G. 1981. Light and electron microscopic localization of silver in biological tissue. Histochemistry 71:177-186
13. Day WA, Hunt JS, McGiven AR. 1976. Silver deposition in mouse glomeruli. Pathology 8:201-204
14. Edwards-Jones V. 2009. The benefits of silver in hygiene, personal care and healthcare. Lett Appl Microbiol 49:147-152
15. Ernst E, Rungby J, Baatrup E. 1991. Ultrastructural localization of silver in rat testis and organ distribution of radioactive silver in the rat. J Appl Toxicol 11:317-321
16. Eom HJ, Choi J. 2010. p38 MAPK activation, DNA damage, cell cycle arrest and apoptosis as mechanisms of toxicity of silver nanoparticles in Jurkat T cells. Environ Sci Technol 44:8337-8342
17. Florea AM, Busselberg D. 2006. Occurrence, use and potential toxic effects of metals and metal compounds. Biometals 19:419-427
18. Genter MB, Newman NC, Shertzer HG, Ali SF, Bolon B. 2012. Distribution and systemic effects of intranasally administered 25 nm silver nanoparticles in adult mice. Toxicol Pathol 40:1004-1013
19. Hackenberg S, Scherzed A, Kessler M, Hummel S, Technau A, Froelich K, et al. 2011. Silver nanoparticles: Evaluation of DNA damage, toxicity and functional impairment in human mesenchymal stem cells. Toxicol Lett 201:27-33
20. Ham KN, Tange JD. 1972. Silver deposition in rat glomerular basement membrane. Aust J Exp Biol Med Sci 50:423-434
21. Isomaa B, Ekman K. 1975. Embryotoxic and teratogenic effects of CTAB, a cationic surfactant, in the mouse. Food Cosmet Toxicol 13:331-334
22. Johnston HJ, Hutchison G, Christensen FM, Peters S, Hankin S, Stone V. 2010. A review of the in vivo and in vitro toxicity of silver and gold particulates: Particle attributes and biological mechanisms responsible for the observed toxicity. Crit Rev Toxicol 40:328-346
23. Kang SJ, Ryoo IG, Lee YJ, Kwak MK. 2012. Role of the Nrf2-heme oxygenase-1 pathway in silver nanoparticle-mediated cytotoxicity. Toxicol Appl Pharmacol 258:89-98
24. Kim WY, Kim J, Park JD, Ryu HY, Yu IJ. 2009. Histological study of gender differences in accumulation of silver nanoparticles in kidneys of Fischer 344 rats. J Toxicol Environ Health A 72:1279-1284
25. Kittler S, Greulich C, Diendorf J, Koller M, Epple M. 2010. Toxicity of silver nanoparticles increases during storage because of slow dissolution under release of silver ions. Chem Mater 22:4548-4554
26. Korani M, Rezayat SM, Gilani K, Arbabi Bidgoli S, Adeli S. 2011. Acute and subchronic dermal toxicity of nanosilver in guinea pig. Int J Nanomedicine 6:855-862
27. Lankveld DP, Oomen AG, Krystek P, Neigh A, Troost-de Jong A, Noorlander CW, et al. 2010. The kinetics of the tissue distribution of silver nanoparticles of different sizes. Biomaterials 31:8350-8361
28. Lee YS, Kim DW, Lee YH, Oh JH, Yoon S, Choi MS, et al. 2011. Silver nanoparticles induce apoptosis and G2/M arrest via PKCzeta-dependent signaling in A549 lung cells. Arch Toxicol 85:1529-1540
29. Li PW, Kuo TH, Chang JH, Yeh JM, Chan WH. 2010. Induction of cytotoxicity and apoptosis in mouse blastocysts by silver nanoparticles. Toxicol Lett 197:82-87
30. Maneewattanapinyo P, Banlunara W, Thammacharoen C, Ekgasit S, Kaewamatawong T. 2011. An evaluation of acute toxicity of colloidal silver nanoparticles. J Vet Med Sci 73:1417-1423
31. Mcquillan JS, Groenaga Infante H, Stokes E, Shaw AM. 2012. Silver nanoparticle enhanced silver ion stress response in Escherichia coli K12. Nanotoxicology 6:857-866
32. Meng J, Yang M, Jia FM, Xu Z, Kong H, Xu HY. 2011. Immune responses of BALB/c mice to subcutaneously injected multi-walled carbon nanotubes. Nanotoxicology 5:583-591
33. Miura N, Shinohara Y. 2009. Cytotoxic effect and apoptosis induction by silver nanoparticles in HeLa cells. Biochem Biophys Res Commun 390:733-737
34. Moffat DB, Creasev M. 1972. The distribution of ingested silver in the kidney of the rat and of the rabbit. Acta Anat (Basel) 83:346-355
35. Nallathamby PD, Xu XH. 2010. Study of cytotoxic and therapeutic effects of stable and purified silver nanoparticles on tumor cells. Nanoscale 2:942-952
36. Park EJ, Bae E, Yi J, Kim Y, Choi K, Lee SH, et al. 2010. Repeated-dose toxicity and inflammatory responses in mice by oral administration of silver nanoparticles. Environ Toxicol Pharmacol 30:162-168
37. Piao MJ, Kang KA, Lee IK, Kim HS, Kim S, Choi JY, et al. 2011a. Silver nanoparticles induce oxidative cell damage in human liver cells through inhibition of reduced glutathione and induction of mitochondria-involved apoptosis. Toxicol Lett 201:92-100
38. Piao MJ, Kim KC, Choi JY, Choi J, Hyun JW. 2011b. Silver nanoparticles down-regulate Nrf2-mediated 8-oxoguanine DNA glycosylase 1 through inactivation of extracellular regulated kinase and protein kinase B in human Chang liver cells. Toxicol Lett 207:143-148
39. Sanpui P, Chattopadhyay A, Ghosh SS. 2011. Induction of apoptosis in cancer cells at low silver nanoparticle concentrations using chitosan nanocarrier. ACS Appl Mater Interfaces 3:218-228
40. Singh SK, Goswami K, Sharma RD, Reddy MV, Dash D. 2012. Novel microfilaricidal activity of nanosilver. Int J Nanomedicine 7:1023-1030
41. Sondi I, Salopek-Sondi B. 2004. Silver nanoparticles as antimicrobial agent: A case study on E. coli as a model for gram-negative bacteria. J Colloid Interface Sci 275:177-182
42. Teodoro JS, Simoes AM, Duarte FV, Rolo AP, Murdoch RC, Hussain SM, et al. 2011. Assessment of the toxicity of silver nanoparticles in vitro: A mitochondrial perspective. Toxicol In Vitro 25:664-670
43. Tiwari DK, Jin T, Behari J. 2011. Dose-dependent in-vivo toxicity assessment of silver nanoparticle in Wistar rats. Toxicol Mech Methods 21:13-24
44. van der Zande M, Vandebriel RJ, Van Doren E, Kramer E, Herrera Rivera Z, Serrano-Rojero CS, et al. 2012. Distribution, elimination, and toxicity of silver nanoparticles and silver ions in rats after 28-day oral exposure. ACS Nano 6:7427-7442
45. Wijnhoven SWP, Peijnenburg WJGM, Herberts CA, Hagens WI, Oomen AG, Heugens EHW, et al. 2009. Nano-silver-A review of available data and knowledge gaps in human and environmental risk assessment. Nanotoxicology 3:109-U78
46. Xiang YU, Wu XC, Liu DF, Li ZY, Chu WG, Feng LL, et al. 2008. Gold nanorod-seeded growth of silver nanostructures: From homogeneous coating to anisotropic coating. Langmuir 24:3465-3470
47. Xiu ZM, Zhang QB, Puppala HL, Colvin VL, Alvarez PJ. 2012. Negligible particle-specific antibacterial activity of silver nanoparticles. Nano Lett 12:4271-4275
48. Zook JM, Long SE, Cleveland D, Geronimo CL, Maccuspie RI. 2011. Measuring silver nanoparticle dissolution in complex biological and environmental matrices using UV-visible absorbance. Anal Bioanal Chem 401:1993-2002